These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 23761833)

  • 1. Complete remission of ALK-negative plasma cell granuloma (inflammatory myofibroblastic tumor) of the lung induced by celecoxib: A case report and review of the literature.
    Chavez C; Hoffman MA
    Oncol Lett; 2013 May; 5(5):1672-1676. PubMed ID: 23761833
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A case report: Pharmacology and resistance patterns of three generations of ALK inhibitors in metastatic inflammatory myofibroblastic sarcoma.
    Parker BM; Parker JV; Lymperopoulos A; Konda V
    J Oncol Pharm Pract; 2019 Jul; 25(5):1226-1230. PubMed ID: 29925295
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anaplastic lymphoma kinase inhibitor therapy in the treatment of inflammatory myofibroblastic tumors in pediatric patients: Case reports and literature review.
    Craig E; Wiltsie LM; Beaupin LK; Baig A; Kozielski R; Rothstein DH; Li V; Twist CJ; Barth M
    J Pediatr Surg; 2021 Dec; 56(12):2364-2371. PubMed ID: 33676744
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inflammatory myofibroblastic tumors of the central nervous system that express anaplastic lymphoma kinase have a high recurrence rate.
    Denis DJ; Elayoubi K; Weil AG; Berthelet F; Bojanowski MW
    Surg Neurol Int; 2013; 4():70. PubMed ID: 23776756
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Durable response to the ALK inhibitor alectinib in inflammatory myofibroblastic tumor of the head and neck with a novel SQSTM1-ALK fusion: a case report.
    Honda K; Kadowaki S; Kato K; Hanai N; Hasegawa Y; Yatabe Y; Muro K
    Invest New Drugs; 2019 Aug; 37(4):791-795. PubMed ID: 30790150
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anaplastic lymphoma kinase-positive pulmonary inflammatory myofibroblastic tumour: a case report.
    Tong D; Chisholm J; Madden B; Ahmed M
    J Med Case Rep; 2024 Apr; 18(1):167. PubMed ID: 38594735
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Crizotinib in ALK
    Theilen TM; Soerensen J; Bochennek K; Becker M; Schwabe D; Rolle U; Klingebiel T; Lehrnbecher T
    Pediatr Blood Cancer; 2018 Apr; 65(4):. PubMed ID: 29286567
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epithelioid inflammatory myofibroblastic sarcoma: An aggressive intra-abdominal variant of inflammatory myofibroblastic tumor with nuclear membrane or perinuclear ALK.
    Mariño-Enríquez A; Wang WL; Roy A; Lopez-Terrada D; Lazar AJ; Fletcher CD; Coffin CM; Hornick JL
    Am J Surg Pathol; 2011 Jan; 35(1):135-44. PubMed ID: 21164297
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Crizotinib in patients with advanced, inoperable inflammatory myofibroblastic tumours with and without anaplastic lymphoma kinase gene alterations (European Organisation for Research and Treatment of Cancer 90101 CREATE): a multicentre, single-drug, prospective, non-randomised phase 2 trial.
    Schöffski P; Sufliarsky J; Gelderblom H; Blay JY; Strauss SJ; Stacchiotti S; Rutkowski P; Lindner LH; Leahy MG; Italiano A; Isambert N; Debiec-Rychter M; Sciot R; Van Cann T; Marréaud S; Nzokirantevye A; Collette S; Wozniak A
    Lancet Respir Med; 2018 Jun; 6(6):431-441. PubMed ID: 29669701
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment modalities of ALK-positive relapsed/refractory inflammatory myofibroblastic tumor of the brain and lungs in 7-year-old girl: case-based reviews.
    Chanthong S; Sathitsamitphong L; Natesirinilkul R; Charoenkwan P; Suwansirikul S; Choed-Amphai C
    Childs Nerv Syst; 2023 Feb; 39(2):331-342. PubMed ID: 36515740
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recurrent uterine inflammatory myofibroblastic tumor previously managed as leiomyosarcoma has sustained response to alectinib.
    Carballo EV; Pham TV; Turashvili G; Hanley K; Starbuck KD; Meisel JL
    Gynecol Oncol Rep; 2022 Oct; 43():101062. PubMed ID: 36032811
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inflammatory myofibroblastic tumor of the uterus - case report.
    Štiková Z; Ptáková N; Horáková M; Kosťun J; Ondič O
    Cesk Patol; 2019; 55(4):239-243. PubMed ID: 31842556
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effectiveness of Crizotinib for Inflammatory Myofibroblastic Tumor with ALK mutation.
    Ogata M; Hatachi Y; Ogata T; Satake H; Imai Y; Yasui H
    Intern Med; 2019 Apr; 58(7):1029-1032. PubMed ID: 30449794
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lorlatinib for the treatment of inflammatory myofibroblastic tumour with TPM4-ALK fusion following failure of entrectinib.
    Wong HH; Bentley H; Bulusu VR; Anyaegbu G; Watkins J; Horan G; Hatcher H
    Anticancer Drugs; 2020 Nov; 31(10):1106-1110. PubMed ID: 32868646
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ALK-1-positive inflammatory myofibroblastic tumor of the thyroid complicated by Hashimoto's thyroiditis: report of a rare case and a literature review.
    Li CF; Wu XL; Wang JJ; Wang K; Zhang SY; Huang JJ; Hu HZ; Zheng H
    Diagn Pathol; 2020 May; 15(1):58. PubMed ID: 32430041
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficiency of Crizotinib on an ALK-Positive Inflammatory Myofibroblastic Tumor of the Central Nervous System: A Case Report.
    Chennouf A; Arslanian E; Roberge D; Berthelet F; Bojanowski M; Bahary JP; Masucci L; Belanger K; Florescu M; Wong P
    Cureus; 2017 Mar; 9(3):e1068. PubMed ID: 28409069
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inflammatory myofibroblastic tumor with predominant anaplastic lymphoma kinase-positive cells lacking a myofibroblastic phenotype.
    Hisaoka M; Shimajiri S; Matsuki Y; Meis-Kindblom JM; Kindblom LG; Li XQ; Wang J; Hashimoto H
    Pathol Int; 2003 Jun; 53(6):376-81. PubMed ID: 12787312
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety and activity of crizotinib for paediatric patients with refractory solid tumours or anaplastic large-cell lymphoma: a Children's Oncology Group phase 1 consortium study.
    Mossé YP; Lim MS; Voss SD; Wilner K; Ruffner K; Laliberte J; Rolland D; Balis FM; Maris JM; Weigel BJ; Ingle AM; Ahern C; Adamson PC; Blaney SM
    Lancet Oncol; 2013 May; 14(6):472-80. PubMed ID: 23598171
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epithelioid inflammatory myofibroblastic sarcoma: a case report.
    Sarmiento DE; Clevenger JA; Masters GA; Bauer TL; Nam BT
    J Thorac Dis; 2015 Oct; 7(10):E513-6. PubMed ID: 26623133
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inflammatory myofibroblastic tumor of bone harboring an ALK gene amplification.
    Wang K; Guo R; Siegal GP; Wei S
    Pathol Res Pract; 2019 Sep; 215(9):152535. PubMed ID: 31326196
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.